(Q42494253)

1 November 2017

Increased cardiovascular risk factors and features of endothelial activation and dysfunction in dialyzed uremic patients (English)

1 reference

1 November 2017

0 references

1 reference

1

Gris JC

1 reference

1 November 2017

Branger B

2

1 reference

1 November 2017

Vécina F

3

1 reference

1 November 2017

al Sabadani B

4

1 reference

1 November 2017

Fourcade J

5

1 reference

1 November 2017

Schved JF

6

1 reference

1 November 2017

language of work or name

English

0 references

publication date

1 September 1994

1 reference

1 November 2017

1 reference

1 November 2017

46

1 reference

1 November 2017

3

1 reference

1 November 2017

807-813

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.1994.336

1 November 2017

0 references

cites work

Accelerated atherosclerosis in prolonged maintenance hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.336

7 January 2021

The pathogenesis of atherosclerosis--an update

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.336

7 January 2021

Features of endothelial dysfunction in early diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.336

7 January 2021

Deamino-8-D-Arginine Vasopressin Shortens the Bleeding Time in Uremia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.336

7 January 2021

Fibrinogen as a risk factor for stroke and myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.336

7 January 2021

Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.336

7 January 2021

Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.336

7 January 2021

On the usefulness of fibrinolysis variables in the characterization of a risk group for myocardial reinfarction

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.336

7 January 2021

Enhanced coagulation-fibrinolysis in patients on regular hemodialysis treatment

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.336

7 January 2021

Factor VIII and chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.336

7 January 2021

Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.336

7 January 2021

Plasma von Willebrand factor and thrombomodulin as markers of vascular disorders in patients undergoing regular hemodialysis therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.336

7 January 2021

Heparin inactivation during blood storage: its prevention by blood collection in citric acid, theophylline, adenosine, dipyridamole-C.T.A.D. mixture

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.336

7 January 2021

[Rapid physiological coagulation method in determination of fibrinogen]

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.336

7 January 2021

Determination of plasminogen activator inhibitor in plasma using t-PA and a chromogenic single-point poly-D-lysine stimulated assay

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.336

7 January 2021

Heparin cofactor activity measured with an amidolytic method

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.336

7 January 2021

Radioimmunoassay of urokinase for quantification of plasminogen activators released in ovarian tumour cultures

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.336

7 January 2021

Antithrombin III and arterial disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.336

7 January 2021

Association between serum albumin and mortality from cardiovascular disease, cancer, and other causes

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.336

7 January 2021

Physiological mechanisms in coagulation and fibrinolysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.336

7 January 2021

Plasma plasminogen activator inhibitor-1 in angina pectoris. Influence of plasma insulin and acute-phase response

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.336

7 January 2021

Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.336

7 January 2021

Tumor necrosis factor-alpha in human arterial wall with atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.336

7 January 2021

Biosynthesis of von Willebrand protein by human megakaryocytes

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.336

7 January 2021

Response of factor VIII/von Willebrand factor to DDAVP in healthy subjects and patients with haemophilia A and von Willebrand's disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.336

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.336

7 January 2021

Coagulation, fibrinolysis, and kallikrein systems in sepsis: relation to outcome

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.336

7 January 2021

Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.336

7 January 2021

Activation of platelets, coagulation and fibrinolysis in patients on long-term haemodialysis: influence of cuprophan and polyacrylonitrile membranes

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.336

7 January 2021

Sequential changes in factor VIII and platelets preceding deep vein thrombosis in patients with spinal cord injury

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.336

7 January 2021

Role of von Willebrand factor in the vessel wall

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.336

7 January 2021

Thrombin stimulates tissue plasminogen activator release from cultured human endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.336

7 January 2021

Biological control of tissue plasminogen activator-mediated fibrinolysis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.336

7 January 2021

Thrombomodulin is present in human plasma and urine

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.336

7 January 2021

Single-chain urokinase-type plasminogen activator: mechanism of action and thrombolytic properties

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.336

7 January 2021

Effects of cytokines on vascular endothelium: their role in vascular and immune injury

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.336

7 January 2021

Identifiers

DOI

10.1038/KI.1994.336

1 reference

Dimensions Publication ID

1 November 2017

0 references

1 reference